Stay updated with breaking news from Pathogen Detection. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nephros, Inc. (NASDAQ:NEPH – Get Rating) was the recipient of a large increase in short interest during the month of May. As of May 31st, there was short interest totalling 51,000 shares, an increase of 82.1% from the May 15th total of 28,000 shares. Currently, 0.6% of the company’s shares are sold short. Based on […]
Beauty Health (NASDAQ:SKIN – Get Rating) and Nephros (NASDAQ:NEPH – Get Rating) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, dividends, analyst recommendations and profitability. Analyst Recommendations This is a breakdown of current ratings for Beauty […]
/PRNewswire/ -- The "Point-of-Care, Biosensors and Mobile Diagnostics Europe 2022" conference has been added to ResearchAndMarkets.com's offering. This...
A number of research firms have changed their ratings and price targets for Nephros (NASDAQ: NEPH): 4/20/2022 – Nephros was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “buy” rating. They now have a $5.25 price target on the stock. According to Zacks, “Nephros develops advanced End Stage Renal Disease, […]
The "Point-of-Care, Biosensors and Mobile Diagnostics Europe 2022" conference has been added to ResearchAndMarkets.com's offering. This conference will provide an overview of the point-of-care (POC)